Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Determining treatment efficacy and biomarkers of response to dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation as a treatment for treatment-refractory anorexia nervosa binge/purge subtype and bulimia nervosa: A multimodal, machine learning, triple-blind sham-controlled study
EF 2014-15
Résumé
5% of female Canadian adolescents have an eating disorder (ED), including anorexia nervosa (AN) and bulimia nervosa (BN). 10% of AN sufferers will die within 10 years of disorder onset. Little change to treatment options and outcomes has occurred over the past 50 years. New treatment approaches are urgently needed; especially for those that are unresponsive to conventional treatments. The development of novel treatment approaches would have the potential to reduce mortality in ED. Costs associated with disability, hospitalization, and day-hospital care would also reduce. Repetitive transcranial magnetic stimulation (rTMS) is a potential treatment for ED. rTMS is a form of non-invasive neuromodulation that uses focused, powerful magnetic field pulses to induce changes in the activity of brain regions. One potential target is a region of the prefrontal cortex, the dorsomedial prefrontal cortex (dmPFC). The dmPFC plays a role in forms of self-control, and is abnormally activated in ED. Our group recently treated major depression with dmPFC-rTMS, achieving promising results. Serendipitously, we also reported a case of a depressed patient with chronic BN who achieved marked improvements following dmPFC-rTMS. As a result, we conducted a follow-up study in additional ED patients. 16 of 28 patients achieved a 50% or more improvement in binge/purge frequency following dmPFC-rTMS. We also used functional magnetic resonance imaging (fMRI) to identify neuroimaging predictors of treatment response. Regions that predicted response were associated with disordered eating, and reward processing. Changes in brain activity in association with improvement were responsible for craving control and reward processing. The current proposal is a follow-up on our preliminary findings: a sham-controlled trial of dmPFC-rTMS for AN and BN to evaluate the efficacy of rTMS. A suite of neuroimaging, clinical and psychometric data will be collected to identify predictors of response to rTMS.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318244
Name
Dunlop Katharine A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Determining treatment efficacy and biomarkers of response to dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation as a treatment for treatment-refractory anorexia nervosa binge/purge subtype and bulimia nervosa: A multimodal, machine learning, triple-blind sham-controlled study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Dorsomedial Prefrontal Cortex; Eating Disorders; Resting-State Fmri; Support Vector Machines; Transcranial Magnetic Stimulation
Abstract
5% of female Canadian adolescents have an eating disorder (ED), including anorexia nervosa (AN) and bulimia nervosa (BN). 10% of AN sufferers will die within 10 years of disorder onset. Little change to treatment options and outcomes has occurred over the past 50 years. New treatment approaches are urgently needed; especially for those that are unresponsive to conventional treatments. The development of novel treatment approaches would have the potential to reduce mortality in ED. Costs associated with disability, hospitalization, and day-hospital care would also reduce. Repetitive transcranial magnetic stimulation (rTMS) is a potential treatment for ED. rTMS is a form of non-invasive neuromodulation that uses focused, powerful magnetic field pulses to induce changes in the activity of brain regions. One potential target is a region of the prefrontal cortex, the dorsomedial prefrontal cortex (dmPFC). The dmPFC plays a role in forms of self-control, and is abnormally activated in ED. Our group recently treated major depression with dmPFC-rTMS, achieving promising results. Serendipitously, we also reported a case of a depressed patient with chronic BN who achieved marked improvements following dmPFC-rTMS. As a result, we conducted a follow-up study in additional ED patients. 16 of 28 patients achieved a 50% or more improvement in binge/purge frequency following dmPFC-rTMS. We also used functional magnetic resonance imaging (fMRI) to identify neuroimaging predictors of treatment response. Regions that predicted response were associated with disordered eating, and reward processing. Changes in brain activity in association with improvement were responsible for craving control and reward processing. The current proposal is a follow-up on our preliminary findings: a sham-controlled trial of dmPFC-rTMS for AN and BN to evaluate the efficacy of rTMS. A suite of neuroimaging, clinical and psychometric data will be collected to identify predictors of response to rTMS.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dunlop, Katharine A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~